Fabry disease in an oligosymptomatic male
- PMID: 21608346
Fabry disease in an oligosymptomatic male
Similar articles
-
Enzyme replacement therapy and Fabry kidney disease: quo vadis?J Am Soc Nephrol. 2007 May;18(5):1368-70. doi: 10.1681/ASN.2007030312. Epub 2007 Apr 11. J Am Soc Nephrol. 2007. PMID: 17429046 No abstract available.
-
Pediatrics: implementing the promise of early intervention for Fabry disease.Clin Ther. 2007;29 Suppl A:S6. doi: 10.1016/s0149-2918(07)80116-0. Clin Ther. 2007. PMID: 17580239 No abstract available.
-
Effects of Enzyme Replacement Therapy and Antidrug Antibodies in Patients with Fabry Disease.J Am Soc Nephrol. 2018 Sep;29(9):2265-2278. doi: 10.1681/ASN.2018030329. Epub 2018 Aug 9. J Am Soc Nephrol. 2018. PMID: 30093456 Free PMC article. Review. No abstract available.
-
Fabry disease--whom to treat and when.Clin Ther. 2008;30 Suppl B:S43-4. doi: 10.1016/s0149-2918(08)80037-9. Clin Ther. 2008. PMID: 18395136 No abstract available.
-
Stroke and Chronic Kidney Disease in Fabry Disease.J Stroke Cerebrovasc Dis. 2021 Sep;30(9):105423. doi: 10.1016/j.jstrokecerebrovasdis.2020.105423. Epub 2020 Nov 5. J Stroke Cerebrovasc Dis. 2021. PMID: 33160817 Review.
Cited by
-
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts.Mol Genet Metab Rep. 2019 Feb 6;19:100454. doi: 10.1016/j.ymgmr.2019.100454. eCollection 2019 Jun. Mol Genet Metab Rep. 2019. PMID: 30775256 Free PMC article. Review.
-
Cerebral hemodynamics and endothelial function in patients with Fabry disease.BMC Neurol. 2013 Nov 11;13:170. doi: 10.1186/1471-2377-13-170. BMC Neurol. 2013. PMID: 24207059 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical